Cargando…

MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer

BACKGROUND: Intracranial progression is considered an important cause of treatment failure in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) patients. Recent advances in targeted therapy and radiomics have generated considerable interest for the exploration of prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shijun, Hou, Donghui, Zheng, Xiaomin, Song, Wei, Liu, Xiaoqing, Wang, Sicong, Zhou, Lina, Tao, Xiuli, Lv, Lv, Sun, Qi, Jin, Yujing, Ding, Lieming, Mao, Li, Wu, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867779/ https://www.ncbi.nlm.nih.gov/pubmed/33569319 http://dx.doi.org/10.21037/tlcr-20-361

Ejemplares similares

Association of anaplastic lymphoma kinase variants and alterations with ensartinib response duration in non‐small cell lung cancer
por: Hou, Donghui, et al.
Publicado: (2021)

Radiomics of liver MRI predict metastases in mice
por: Becker, Anton S., et al.
Publicado: (2018)

PET/MRI Radiomics in Patients With Brain Metastases
por: Lohmann, Philipp, et al.
Publicado: (2020)

Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases
por: Bodalal, Zuhir, et al.
Publicado: (2023)

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas
por: Sun, Shuchen, et al.
Publicado: (2022)

Multisequence MRI-based radiomics nomogram for early prediction of osimertinib resistance in patients with non-small cell lung cancer brain metastases
por: Lv, Xinna, et al.
Publicado: (2023)

MRI-based Radiomics nomogram to detect primary rectal cancer with synchronous liver metastases
por: Shu, Zhenyu, et al.
Publicado: (2019)

Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases—a multicenter retrospective study
por: Zou, Zihua, et al.
Publicado: (2022)

Radiomic Signatures for Predicting Receptor Status in Breast Cancer Brain Metastases
por: Luo, Xiao, et al.
Publicado: (2022)

Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients
por: Song, Lan, et al.
Publicado: (2020)

Radiomics Analysis of Multiparametric MRI for Prediction of Synchronous Lung Metastases in Osteosarcoma
por: Luo, Zhendong, et al.
Publicado: (2022)

Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases
por: Fan, Ying, et al.
Publicado: (2022)

MRI‐based radiomic signatures for pretreatment prognostication in cervical cancer
por: Wagner‐Larsen, Kari S., et al.
Publicado: (2023)

Radiomics biopsy signature for predicting survival in patients with spinal bone metastases (SBMs)
por: Sanli, I., et al.
Publicado: (2022)

Radiomic Signatures for Predicting EGFR Mutation Status in Lung Cancer Brain Metastases
por: Zheng, Lie, et al.
Publicado: (2022)

Pretreatment Thoracic CT Radiomic Features to Predict Brain Metastases in Patients With ALK-Rearranged Non-Small Cell Lung Cancer
por: Wang, Hua, et al.
Publicado: (2022)

The Impact of Resampling and Denoising Deep Learning Algorithms on Radiomics in Brain Metastases MRI
por: Moummad, Ilyass, et al.
Publicado: (2021)

The Application of DTCWT on MRI-Derived Radiomics for Differentiation of Glioblastoma and Solitary Brain Metastases
por: Wu, Wen-Feng, et al.
Publicado: (2022)

An MRI-based radiomics nomogram for differentiating spinal metastases from multiple myeloma
por: Zhang, Shuai, et al.
Publicado: (2023)

Non-Mass Enhancements on DCE-MRI: Development and Validation of a Radiomics-Based Signature for Breast Cancer Diagnoses
por: Li, Yan, et al.
Publicado: (2021)

Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis
por: Zhang, Li, et al.
Publicado: (2022)

MRI Radiomic Signature of White Matter Hyperintensities Is Associated With Clinical Phenotypes
por: Bretzner, Martin, et al.
Publicado: (2021)

CT-Based Radiomics Signatures for Predicting the Risk Categorization of Thymic Epithelial Tumors
por: Liu, Jin, et al.
Publicado: (2021)

Morphology-based radiomics signature: a novel determinant to identify multiple intracranial aneurysms rupture
por: Tong, Xin, et al.
Publicado: (2021)

Differentiation of Glioblastoma and Brain Metastases by MRI-Based Oxygen Metabolomic Radiomics and Deep Learning
por: Stadlbauer, Andreas, et al.
Publicado: (2022)

MRI feature-based radiomics models to predict treatment outcome after stereotactic body radiotherapy for spinal metastases
por: Chen, Yongye, et al.
Publicado: (2023)

Different Clinicopathologic and Computed Tomography Imaging Characteristics of Primary and Acquired EGFR T790M Mutations in Patients with Non-Small-Cell Lung Cancer
por: Hou, Donghui, et al.
Publicado: (2021)

MRI-based radiomics signature is a quantitative prognostic biomarker for nasopharyngeal carcinoma
por: Ming, Xue, et al.
Publicado: (2019)

Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures
por: Mes, Steven W., et al.
Publicado: (2020)

Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature
por: Zhang, Li, et al.
Publicado: (2021)

The Role of an MRI-Based Radiomic Signature in Predicting Malignancy of Parotid Gland Tumors
por: Muntean, Delia Doris, et al.
Publicado: (2023)

22. COMPARATIVE EFFICACY OF ALK-INHIBITORS IN ALK INHIBITOR-NAIVE ALK+ LUNG CANCER BRAIN METASTASES: A NETWORK META-ANALYSIS
por: Haddad, Philip, et al.
Publicado: (2020)

Whole-liver enhanced CT radiomics analysis to predict metachronous liver metastases after rectal cancer surgery
por: Liang, Meng, et al.
Publicado: (2022)

Radiomics Signatures of Cardiovascular Risk Factors in Cardiac MRI: Results From the UK Biobank
por: Cetin, Irem, et al.
Publicado: (2020)

MRI-Based Radiomic Signature Identifying Secondary Loss of Response to Infliximab in Crohn's Disease
por: Feng, Jing, et al.
Publicado: (2022)

Quantitative evaluation of the infrapatellar fat pad in knee osteoarthritis: MRI-based radiomic signature
por: Ye, Qin, et al.
Publicado: (2023)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

T2-Weighted Image-Based Radiomics Signature for Discriminating Between Seminomas and Nonseminoma
por: Zhang, Peipei, et al.
Publicado: (2019)

Predicting response to radiotherapy of intracranial metastases with hyperpolarized [Formula: see text] C MRI
por: Lee, Casey Y., et al.
Publicado: (2021)

Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer
por: Chen, Bihong T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_keu5mdg7qpsh8lcj4vg109o777